Agios Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.71 billion, with shareholders equity totaling $979.34 million.
The company employs approximately 530 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Agios Pharmaceuticals Inc. reported $140.84 million in revenue, generating net income of $-372.90 million.
Key financial metrics include a P/E ratio of -4.58, a price-to-book (P/B) ratio of 1.74, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker AGIO.